Schedule 13D ownership disclosure
Black Diamond Therapeutics Inc
Security class unavailable · CUSIP: 09203E105
Event date: 2020-02-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,589,904
- Percent of class
- 7.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-011358
- Form type
- SC 13D
- Filer
- Black Diamond Therapeutics, Inc.
- CIK
- CIK 1701541
- Filed
- Feb 05, 2020
- Reporting period
- Feb 03, 2020
- Description
- Schedule 13D beneficial ownership